T1	Treatment 91 116	gamma-secretase inhibitor
T2	Treatment 260 268	LY450139
T3	Treatment 574 624	using doses from 5 to 50 mg/day given for 14 days.
T4	Treatment 625 711	Plasma and CSF concentrations of LY450139, Abeta(1-40) and Abeta(1-X) ("Abeta(total)")
T5	Treatment 1582 1590	LY450139
